• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高龄心力衰竭患者中的肥胖悖论:一项回顾性队列研究。

The obesity paradox in super-elderly patients with heart failure: a retrospective cohort study.

作者信息

Tachibana Takahiro, Kubota Yoshiaki, Nishino Takuya, Kato Katsuhito, Iwade Yoshiki, Hayashi Daisuke, Watanabe Yukihiro, Miyachi Hideki, Tara Shuhei, Asai Kuniya

机构信息

Department of Cardiovascular Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Department of Health Care Administration, Nippon Medical School, Tokyo, Japan.

出版信息

Heart Vessels. 2025 Sep 17. doi: 10.1007/s00380-025-02597-5.

DOI:10.1007/s00380-025-02597-5
PMID:40960537
Abstract

Obesity is an independent risk factor for heart failure (HF) onset; however, weight loss is an independent poor prognostic factor in patients with HF. According to the obesity paradox, higher body weight is associated with better prognosis in these patients. This retrospective cohort study investigated the obesity paradox in super-elderly, understudied patients (aged ≥ 85 years) with HF and examined its impact on all-cause mortality. We included patients hospitalized for HF between April 2015 and March 2023. Participants were divided into four age groups: Groups A (< 65 years), B (65-74 years), C (75-84 years, elderly), and D (≥ 85 years, super-elderly). The primary endpoint was the 1-year all-cause mortality rate after discharge. The secondary endpoints included cardiac and non-cardiac death rates and all-cause mortality rates stratified by left ventricular ejection fraction (LVEF). Overall, 3,811 individuals (mean age: 74.3 years, 60.4% men) were included. A trend toward higher all-cause mortality rates associated with underweight (body mass index [BMI] < 18.5 kg/m) was observed in all age groups. Patients with obesity (BMI ≥ 25.0 kg/m) had significantly better survival than other patients. Underweight was associated with a higher cardiac death rate compared with the other weight categories (P = 0.014, 0.039, and 0.022 for groups B, C, and D, respectively). In the analysis stratified by LVEF, underweight was significantly associated with a higher cardiac death rate in patients with HF with preserved LVEF compared with the other weight categories (P < 0.001). The obesity paradox in the super-elderly population was confirmed. It is important to consider BMI in HF management and prognosis.

摘要

肥胖是心力衰竭(HF)发病的独立危险因素;然而,体重减轻是HF患者独立的不良预后因素。根据肥胖悖论,较高的体重与这些患者较好的预后相关。这项回顾性队列研究调查了超老年、研究较少的HF患者(年龄≥85岁)中的肥胖悖论,并研究了其对全因死亡率的影响。我们纳入了2015年4月至2023年3月因HF住院的患者。参与者分为四个年龄组:A组(<65岁)、B组(65 - 74岁)、C组(75 - 84岁,老年)和D组(≥85岁,超老年)。主要终点是出院后1年的全因死亡率。次要终点包括心脏和非心脏死亡率以及按左心室射血分数(LVEF)分层的全因死亡率。总体而言,共纳入3811名个体(平均年龄:74.3岁,男性占60.4%)。在所有年龄组中均观察到体重过轻(体重指数[BMI]<18.5 kg/m)与较高的全因死亡率相关的趋势。肥胖患者(BMI≥25.0 kg/m)的生存率明显高于其他患者。与其他体重类别相比,体重过轻与较高的心脏死亡率相关(B组、C组和D组的P值分别为0.014、0.039和0.022)。在按LVEF分层的分析中,与其他体重类别相比,体重过轻与LVEF保留的HF患者较高的心脏死亡率显著相关(P<0.001)。超老年人群中的肥胖悖论得到了证实。在HF管理和预后中考虑BMI很重要。

相似文献

1
The obesity paradox in super-elderly patients with heart failure: a retrospective cohort study.高龄心力衰竭患者中的肥胖悖论:一项回顾性队列研究。
Heart Vessels. 2025 Sep 17. doi: 10.1007/s00380-025-02597-5.
2
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial.体重指数、中心性肥胖和体重减轻对替尔泊肽治疗射血分数保留的心力衰竭(HFpEF)疗效的影响:SUMMIT试验
J Am Coll Cardiol. 2025 Jul 29;86(4):242-255. doi: 10.1016/j.jacc.2025.04.059.
4
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
5
Association between sodium-glucose Co-transporter-2 inhibitor use and prognosis in underweight patients with diabetes mellitus and heart failure.钠-葡萄糖协同转运蛋白2抑制剂的使用与体重过低的糖尿病合并心力衰竭患者预后之间的关联。
Clin Nutr ESPEN. 2025 Oct;69:767-774. doi: 10.1016/j.clnesp.2025.08.031. Epub 2025 Sep 2.
6
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials.沙库巴曲缬沙坦对心力衰竭患者全因住院的影响:PARADIGM-HF 和 PARAGON-HF 随机临床试验的事后分析。
JAMA Cardiol. 2024 Nov 1;9(11):1047-1052. doi: 10.1001/jamacardio.2024.2566.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
Partial obesity paradox regarding mortality in patients hospitalized with diastolic or systolic heart failure.舒张性或收缩性心力衰竭住院患者死亡率方面的部分肥胖悖论。
Future Cardiol. 2025 Apr;21(5):283-290. doi: 10.1080/14796678.2025.2477421. Epub 2025 Mar 10.
9
Obesity Paradox in the Intrahospital and Follow-Up Phases of the Acute Coronary Syndrome: A Meta-Analysis and Systematic Review.肥胖悖论在急性冠状动脉综合征的院内和随访阶段:荟萃分析和系统评价。
Cardiology. 2023;148(6):528-544. doi: 10.1159/000531985. Epub 2023 Aug 8.
10
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.

本文引用的文献

1
Prognostic impact of frailty based on a comprehensive frailty assessment in patients with heart failure.基于综合虚弱评估的心力衰竭患者虚弱状况对预后的影响。
ESC Heart Fail. 2024 Aug;11(4):2076-2085. doi: 10.1002/ehf2.14728. Epub 2024 Mar 28.
2
Body Mass Index and All-Cause Mortality in Elderly Patients with Percutaneous Coronary Intervention: A Meta-Analysis.体质量指数与经皮冠状动脉介入治疗老年患者全因死亡率的关系:一项荟萃分析。
Obes Facts. 2024;17(3):227-236. doi: 10.1159/000537744. Epub 2024 Feb 14.
3
Update on obesity, the obesity paradox, and obesity management in heart failure.
心力衰竭中肥胖、肥胖悖论和肥胖管理的最新进展。
Prog Cardiovasc Dis. 2024 Jan-Feb;82:34-42. doi: 10.1016/j.pcad.2024.01.003. Epub 2024 Jan 9.
4
Adipokines and Their Role in Heart Failure: A Literature Review.脂肪因子及其在心力衰竭中的作用:文献综述
J Innov Card Rhythm Manag. 2023 Nov 15;14(11):5657-5669. doi: 10.19102/icrm.2023.14111. eCollection 2023 Nov.
5
The Influence of Parents' Background and Their Perception on the Progression of Myopia in Children.父母背景及其观念对儿童近视进展的影响。
Int J Clin Pract. 2022 Nov 24;2022:4123470. doi: 10.1155/2022/4123470. eCollection 2022.
6
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.沙库巴曲缬沙坦与射血分数保留的心力衰竭患者的虚弱。
J Am Coll Cardiol. 2022 Sep 20;80(12):1130-1143. doi: 10.1016/j.jacc.2022.06.037. Epub 2022 Aug 29.
7
The 'obesity paradox' in cardiovascular diseases: age matters!心血管疾病中的“肥胖悖论”:年龄很关键!
Eur J Prev Cardiol. 2022 Aug 5;29(10):1476-1478. doi: 10.1093/eurjpc/zwac150.
8
Clinical implications of low estimated protein intake in patients with heart failure.心力衰竭患者低蛋白估算摄入量的临床意义。
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1762-1770. doi: 10.1002/jcsm.12973. Epub 2022 Apr 14.
9
Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.肥胖与心血管结局的关系:观察性和孟德尔随机化研究的伞状评价和荟萃分析。
Eur Heart J. 2021 Sep 7;42(34):3388-3403. doi: 10.1093/eurheartj/ehab454.
10
Characteristics of Elderly Patients with Heart Failure and Impact on Activities of Daily Living: A Registry Report from Super-Aged Society.老年心力衰竭患者的特征及其对日常生活活动的影响:超级老龄化社会的注册报告。
J Card Fail. 2021 Nov;27(11):1203-1213. doi: 10.1016/j.cardfail.2021.05.008. Epub 2021 May 28.